vs

Side-by-side financial comparison of Babcock & Wilcox Enterprises, Inc. (BW) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $113.4M, roughly 1.8× Babcock & Wilcox Enterprises, Inc.). On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 0.6%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-7.2M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -16.9%).

Babcock & Wilcox Enterprises, Inc. is an American energy technology and service provider that is active and has operations in many international markets with its headquarters in Akron, Ohio. Historically, the company is best known for their steam boilers.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

BW vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.8× larger
IRTC
$208.9M
$113.4M
BW
Growing faster (revenue YoY)
IRTC
IRTC
+26.5% gap
IRTC
27.1%
0.6%
BW
More free cash flow
IRTC
IRTC
$21.7M more FCF
IRTC
$14.5M
$-7.2M
BW
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-16.9%
BW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BW
BW
IRTC
IRTC
Revenue
$113.4M
$208.9M
Net Profit
$5.6M
Gross Margin
20.6%
70.9%
Operating Margin
0.2%
1.1%
Net Margin
2.7%
Revenue YoY
0.6%
27.1%
Net Profit YoY
518.5%
EPS (diluted)
$0.11
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BW
BW
IRTC
IRTC
Q4 25
$113.4M
$208.9M
Q3 25
$149.0M
$192.9M
Q2 25
$144.1M
$186.7M
Q1 25
$181.2M
$158.7M
Q4 24
$112.7M
$164.3M
Q3 24
$152.6M
$147.5M
Q2 24
$151.4M
$148.0M
Q1 24
$164.3M
$131.9M
Net Profit
BW
BW
IRTC
IRTC
Q4 25
$5.6M
Q3 25
$35.1M
$-5.2M
Q2 25
$-58.5M
$-14.2M
Q1 25
$-22.0M
$-30.7M
Q4 24
$-63.1M
$-1.3M
Q3 24
$-5.3M
$-46.2M
Q2 24
$25.4M
$-20.1M
Q1 24
$-16.8M
$-45.7M
Gross Margin
BW
BW
IRTC
IRTC
Q4 25
20.6%
70.9%
Q3 25
24.9%
71.1%
Q2 25
30.0%
71.2%
Q1 25
22.1%
68.8%
Q4 24
16.7%
70.0%
Q3 24
23.7%
68.8%
Q2 24
21.8%
69.9%
Q1 24
23.6%
66.3%
Operating Margin
BW
BW
IRTC
IRTC
Q4 25
0.2%
1.1%
Q3 25
4.4%
-4.4%
Q2 25
5.6%
-10.0%
Q1 25
3.2%
-20.5%
Q4 24
-8.1%
-2.5%
Q3 24
1.0%
-34.1%
Q2 24
-2.9%
-15.5%
Q1 24
3.5%
-28.9%
Net Margin
BW
BW
IRTC
IRTC
Q4 25
2.7%
Q3 25
23.5%
-2.7%
Q2 25
-40.6%
-7.6%
Q1 25
-12.1%
-19.3%
Q4 24
-56.0%
-0.8%
Q3 24
-3.5%
-31.3%
Q2 24
16.8%
-13.6%
Q1 24
-10.2%
-34.6%
EPS (diluted)
BW
BW
IRTC
IRTC
Q4 25
$0.11
$0.18
Q3 25
$0.30
$-0.16
Q2 25
$-0.63
$-0.44
Q1 25
$-0.26
$-0.97
Q4 24
$-0.73
$-0.03
Q3 24
$-0.10
$-1.48
Q2 24
$0.24
$-0.65
Q1 24
$-0.23
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BW
BW
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$89.5M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-131.5M
$152.7M
Total Assets
$662.9M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BW
BW
IRTC
IRTC
Q4 25
$89.5M
$583.8M
Q3 25
$25.2M
$565.2M
Q2 25
$23.4M
$545.5M
Q1 25
$23.5M
$520.6M
Q4 24
$26.9M
$535.6M
Q3 24
$30.6M
$522.0M
Q2 24
$95.5M
$561.5M
Q1 24
$43.9M
$569.1M
Stockholders' Equity
BW
BW
IRTC
IRTC
Q4 25
$-131.5M
$152.7M
Q3 25
$-232.2M
$121.9M
Q2 25
$-309.2M
$103.7M
Q1 25
$-303.0M
$86.7M
Q4 24
$-283.8M
$90.9M
Q3 24
$-203.7M
$71.8M
Q2 24
$-198.9M
$99.2M
Q1 24
$-223.0M
$90.3M
Total Assets
BW
BW
IRTC
IRTC
Q4 25
$662.9M
$1.0B
Q3 25
$657.9M
$995.2M
Q2 25
$703.5M
$964.0M
Q1 25
$719.7M
$926.1M
Q4 24
$727.0M
$931.4M
Q3 24
$804.6M
$909.7M
Q2 24
$849.1M
$919.2M
Q1 24
$795.5M
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BW
BW
IRTC
IRTC
Operating Cash FlowLast quarter
$-3.0M
$26.2M
Free Cash FlowOCF − Capex
$-7.2M
$14.5M
FCF MarginFCF / Revenue
-6.3%
6.9%
Capex IntensityCapex / Revenue
3.7%
5.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$-85.7M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BW
BW
IRTC
IRTC
Q4 25
$-3.0M
$26.2M
Q3 25
$-32.1M
$34.9M
Q2 25
$-25.3M
$27.7M
Q1 25
$-8.5M
$-7.9M
Q4 24
$-22.5M
$19.2M
Q3 24
$-69.5M
$24.3M
Q2 24
$-11.8M
$11.8M
Q1 24
$-14.9M
$-52.0M
Free Cash Flow
BW
BW
IRTC
IRTC
Q4 25
$-7.2M
$14.5M
Q3 25
$-37.6M
$20.1M
Q2 25
$-28.1M
$17.3M
Q1 25
$-12.8M
$-17.3M
Q4 24
$-23.6M
$12.4M
Q3 24
$-71.6M
$15.5M
Q2 24
$-16.4M
$3.4M
Q1 24
$-18.3M
$-61.8M
FCF Margin
BW
BW
IRTC
IRTC
Q4 25
-6.3%
6.9%
Q3 25
-25.3%
10.4%
Q2 25
-19.5%
9.3%
Q1 25
-7.1%
-10.9%
Q4 24
-20.9%
7.5%
Q3 24
-46.9%
10.5%
Q2 24
-10.8%
2.3%
Q1 24
-11.2%
-46.8%
Capex Intensity
BW
BW
IRTC
IRTC
Q4 25
3.7%
5.6%
Q3 25
3.7%
7.7%
Q2 25
1.9%
5.6%
Q1 25
2.4%
5.9%
Q4 24
1.0%
4.2%
Q3 24
1.4%
6.0%
Q2 24
3.0%
5.7%
Q1 24
2.1%
7.4%
Cash Conversion
BW
BW
IRTC
IRTC
Q4 25
4.70×
Q3 25
-0.92×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.46×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BW
BW

Construction$98.8M87%
Other$14.6M13%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons